More good news than bad.... As predicted, inconclusive until August.
Adverse are standard and expected in such trials as they are still attempting to find correct dosage. Almost 7% higher reduction in levels.... Thats significant at this early stage.... As noted, this difference could keep rising into the later stages of the trial. 7% is on a population basis which could mean the difference between reduction and erradication....
IND full steam ahead
BIT Price at posting:
11.0¢ Sentiment: Hold Disclosure: Held
